| pubmed-article:18165641 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C1512162 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:18165641 | lifeskim:mentions | umls-concept:C1518422 | lld:lifeskim |
| pubmed-article:18165641 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18165641 | pubmed:dateCreated | 2007-12-31 | lld:pubmed |
| pubmed-article:18165641 | pubmed:abstractText | Fit elderly patients with advanced non-small-cell lung cancer (NSCLC) benefit from platinum-based, two-drug chemotherapy. Bevacizumab (B) in combination with carboplatin (C) and paclitaxel (P) improves survival for advanced, nonsquamous NSCLC, as evidenced in Eastern Cooperative Oncology Group (ECOG) 4599. We conducted a subset analysis of ECOG 4599 to determine the outcome for elderly patients. | lld:pubmed |
| pubmed-article:18165641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18165641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18165641 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18165641 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18165641 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18165641 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18165641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18165641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18165641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18165641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18165641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18165641 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18165641 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:18165641 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:Eastern... | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:SchillerJoan... | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:BelaniChandra... | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:JohnsonDavid... | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:LangerCorey... | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:GrayRobertR | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:BrahmerJulie... | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:SandlerAlan... | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:DahlbergSuzan... | lld:pubmed |
| pubmed-article:18165641 | pubmed:author | pubmed-author:RamalingamSur... | lld:pubmed |
| pubmed-article:18165641 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18165641 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:18165641 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:18165641 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18165641 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18165641 | pubmed:pagination | 60-5 | lld:pubmed |
| pubmed-article:18165641 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:meshHeading | pubmed-meshheading:18165641... | lld:pubmed |
| pubmed-article:18165641 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18165641 | pubmed:articleTitle | Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599. | lld:pubmed |
| pubmed-article:18165641 | pubmed:affiliation | Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, USA. suresh.ramalingam@emory.edu | lld:pubmed |
| pubmed-article:18165641 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18165641 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18165641 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18165641 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18165641 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18165641 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18165641 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18165641 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18165641 | lld:pubmed |
